Anebulo Pharmaceuticals, Inc. (ANEB) Reports Q1 Loss of $0.08
Tweet
Share
E-mailGet Alerts ANEB Hot Sheet
Join SI Premium – FREE
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q1 EPS of ($0.08).
For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
- Independence Realty Trust (IRT) files mixed shelf
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
